Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFICIONADO: Insulin Glargine Titration in Type 2 Diabetes
NCT01127269Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2010
- Primary completion
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started May 2010; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01127269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127269.